XBiotech Inc. (XBIT) stock
XBITNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.96+0.00 (0.00%)
Close on Nov 13, 2026Market cap $59.76MP/E –Yield –
XBiotech cash
Cash and short-term investments held at the end of each period.
XBiotech's cash was $105.04M at Sep 30, 2026. For fiscal 2025 it was $125.55M, down 27.3% from the year before. Over ten years it grew 3.3% a year on average. The highest annual figure on record is $714.59M in fiscal 2019.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $125.55M | -27.3% |
| FY2024 | Dec 31, 2024 | $172.68M | -13.7% |
| FY2023 | Dec 31, 2023 | $200.02M | -8.0% |
| FY2022 | Dec 31, 2022 | $217.48M | -8.2% |
| FY2021 | Dec 31, 2021 | $236.98M | -0.2% |
| FY2020 | Dec 31, 2020 | $237.37M | -66.8% |
| FY2019 | Dec 31, 2019 | $714.59M | +4416.2% |
| FY2018 | Dec 31, 2018 | $15.82M | -50.2% |
| FY2017 | Dec 31, 2017 | $31.77M | -7.4% |
| FY2016 | Dec 31, 2016 | $34.32M | -62.3% |
| FY2015 | Dec 31, 2015 | $91.05M | +58.8% |
| FY2014 | Dec 31, 2014 | $57.33M | +691.4% |
| FY2013 | Dec 31, 2013 | $7.24M | +73.8% |
| FY2012 | Dec 31, 2012 | $4.17M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $105.04M | -28.7% |
| Q2 FY2026 | Jun 30, 2026 | $109.53M | -28.4% |
| Q1 FY2026 | Mar 31, 2026 | $115.46M | -25.9% |
| Q4 FY2025 | Dec 31, 2025 | $125.55M | -27.3% |
| Q3 FY2025 | Sep 30, 2025 | $147.37M | -19.5% |
| Q2 FY2025 | Jun 30, 2025 | $152.94M | -18.9% |
| Q1 FY2025 | Mar 31, 2025 | $155.90M | -22.5% |
| Q4 FY2024 | Dec 31, 2024 | $172.68M | -13.7% |
| Q3 FY2024 | Sep 30, 2024 | $183.12M | -9.4% |
| Q2 FY2024 | Jun 30, 2024 | $188.53M | -7.9% |
| Q1 FY2024 | Mar 31, 2024 | $201.04M | -5.5% |
| Q4 FY2023 | Dec 31, 2023 | $200.02M | -8.0% |
| Q3 FY2023 | Sep 30, 2023 | $202.19M | -8.1% |
| Q2 FY2023 | Jun 30, 2023 | $204.77M | -9.3% |
| Q1 FY2023 | Mar 31, 2023 | $212.66M | -8.3% |
| Q4 FY2022 | Dec 31, 2022 | $217.48M | -8.2% |
| Q3 FY2022 | Sep 30, 2022 | $220.10M | -7.9% |
| Q2 FY2022 | Jun 30, 2022 | $225.79M | -28.4% |
| Q1 FY2022 | Mar 31, 2022 | $231.82M | -3.4% |
| Q4 FY2021 | Dec 31, 2021 | $236.98M | -0.2% |
| Q3 FY2021 | Sep 30, 2021 | $238.88M | +0.2% |
| Q2 FY2021 | Jun 30, 2021 | $315.26M | +37.2% |
| Q1 FY2021 | Mar 31, 2021 | $239.88M | -0.7% |
| Q4 FY2020 | Dec 31, 2020 | $237.37M | -66.8% |
| Q3 FY2020 | Sep 30, 2020 | $238.43M | +491.1% |
| Q2 FY2020 | Jun 30, 2020 | $229.70M | +411.3% |
| Q1 FY2020 | Mar 31, 2020 | $241.54M | +1909.7% |
| Q4 FY2019 | Dec 31, 2019 | $714.59M | +4416.2% |
| Q3 FY2019 | Sep 30, 2019 | $40.34M | +93.5% |
| Q2 FY2019 | Jun 30, 2019 | $44.92M | +80.8% |
| Q1 FY2019 | Mar 31, 2019 | $12.02M | -57.7% |
| Q4 FY2018 | Dec 31, 2018 | $15.82M | -50.2% |
| Q3 FY2018 | Sep 30, 2018 | $20.85M | -46.5% |
| Q2 FY2018 | Jun 30, 2018 | $24.85M | -45.9% |
| Q1 FY2018 | Mar 31, 2018 | $28.42M | -48.0% |
| Q4 FY2017 | Dec 31, 2017 | $31.77M | -7.4% |
| Q3 FY2017 | Sep 30, 2017 | $38.98M | – |
| Q2 FY2017 | Jun 30, 2017 | $45.95M | – |
| Q1 FY2017 | Mar 31, 2017 | $54.63M | – |
| Q4 FY2016 | Dec 31, 2016 | $34.32M | – |
See a number that looks wrong?